Minimally invasive surgery (MIS) is considered as one of the most important developments in the healthcare industry. A number of companies, especially new entrants from developing nations, are competing to benefit from the rapid growth of this mar ....see more
The global tumor ablation market size is projected to grow at a CAGR of 12.5%. Key players operating in this market are Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.).
The varicose vein treatment market size is projected to grow at a CAGR of 6.9%. The swollen, twisted veins that are visible under the skin are termed as varicose veins.
A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.
The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures.
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.